EI Acquires Majority Stake in Supplement Brand Formeds
Enterprise Investors Backs Poland’s Clean-Label Supplement Brand Formeds with Majority Investment to Capitalize on Growing Health & Wellness Market
In a significant move that strengthens its position in the healthcare and wellness space, Enterprise Investors Fund IX has acquired a 77% stake in Formeds, one of Poland’s leading producers of clean-label dietary supplements. The deal marks a strategic partnership with the company’s co-owner and CEO, Waldemar Pilch, and is subject to antitrust approval. While the transaction value was not disclosed, the deal signals growing investor appetite for consumer health products with strong e-commerce presence and transparent, additive-free formulas.
Founded in 2012, Formeds has carved out a unique identity in Poland’s competitive vitamins and supplements market by offering clean-label formulations—products free from artificial additives, preservatives, and fillers. This positioning aligns with global trends in wellness and self-care, where health-conscious consumers are increasingly drawn to purity, transparency, and efficacy.
Subscribe to Startup Digest to stay ahead with the latest news, investments, and must-attend events.
With over 160 products in its catalog, Formeds addresses key health categories such as immunity, cardiovascular health, digestion, beauty, and prenatal care. The company’s products have gained popularity across both traditional retail and online sales channels, placing it among the most recognized supplement brands in Poland’s digital marketplace. Notably, Formeds owns and operates its own production facility near Poznań, giving it full control over the manufacturing process and ensuring high standards through certified laboratory testing.
A Growing Market Backed by Growing Demand
The investment comes at a time when the global vitamin and supplement market is experiencing accelerated growth, fueled by increased awareness of longevity, preventive health, and lifestyle-based nutrition. According to the company, Formeds is on track to reach €15 million in revenue this year, marking a 46% year-over-year increase—a growth rate that has caught the attention of seasoned investors.
For Enterprise Investors (EI)—one of the most active private equity firms in Central and Eastern Europe—Formeds fits into a broader investment thesis targeting high-growth companies with strong brand recognition and scalable operations. EI’s investment portfolio spans sectors including consumer goods, healthcare, and technology, with over €2.4 billion invested in 161 companies since the firm’s inception in 1990.
“Formeds’ in-house product development capabilities and loyal customer base make it an attractive investment,” said Michał Kędzia, partner at Enterprise Investors. “We see strong potential for sustained growth. Importantly, Mr. Pilch remains actively engaged, providing strategic continuity and founder-driven leadership.”
Next Stage: Gummies, Droplets, and Global Scale
With fresh capital and institutional backing, Formeds now plans to diversify its delivery formats to include liquid supplements, gummies, and droplets, thereby broadening appeal across age groups and consumer preferences. The company also aims to expand its portfolio to address more specific health needs while preserving its commitment to clean-label transparency.
“We built Formeds on a commitment to purity and simplicity,” said Waldemar Pilch, CEO and co-owner. “Partnering with Enterprise Investors allows us to accelerate that vision and reach new customers while continuing to innovate.”
A Strategic Win for Polish Healthtech
The deal underscores the growing maturity of Poland’s health and wellness sector, as private equity firms like EI double down on consumer-facing companies that combine scientific credibility, production control, and strong D2C execution. With a domestic manufacturing base and a digital-first sales model, Formeds is well-positioned to scale regionally—and potentially beyond—while riding a global wave of supplement demand.
